Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 240 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 359 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 320 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 107 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 112 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 117 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 444 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 578 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 0.0 | BCD100322A01 | 166 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 0.5 | BCD100322A03 | 303 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 1.0 | BCD100322A07 | 353 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 2.0 | BCD100322A11 | 416 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 4.0 | BCD100322A15 | 88.4 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 8.0 | BCD100322A19 | 97.8 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 12.0 | BCD100322A23 | 118 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 24.0 | BCD100322A27 | 435 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 367 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 458 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 318 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 119 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 126 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 499 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 664 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 0.5 | BCD100322A04 | 283 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 1.0 | BCD100322A08 | 412 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 2.0 | BCD100322A12 | 144 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 4.0 | BCD100322A16 | 107 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 8.0 | BCD100322A20 | 104 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 12.0 | BCD100322A24 | 99.7 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 24.0 | BCD100322A28 | 547 | pmol/sample |